Want to see CH:ALC full AI Analyst Report?

Alcon (ALC) Price & Analysis

21 Followers

ALC Stock Chart & Stats

CHF58.72

-CHF0.06(-0.11%)

At close: Jul 27 4:00 PM EDT

CHF58.72

-CHF0.06(-0.11%)

Day’s Range― - ―

52-Week RangeCHF47.80 - CHF68.34

Previous CloseN/A

Volume1.70M

Average Volume (3M)983.08K

Market Cap

CHF27.94B

Enterprise ValueCHF29.78B

Total Cash (Recent Filing)CHF1.46B

Total Debt (Recent Filing)CHF5.31B

Price to Earnings (P/E)51.9

Beta1.03

Next Earnings

Nov 10, 2026

EPS Estimate

0.72

Next Dividend Ex-DateN/A

Dividend Yield0.5%

Share Statistics

EPS (TTM)1.29

Shares Outstanding499,700,000

10 Day Avg. Volume966,585

30 Day Avg. Volume983,078

Financial Highlights & Ratios

PEG Ratio39.53

Price to Book (P/B)1.79

Price to Sales (P/S)3.61

P/FCF Ratio21.75

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

CHF68.80

Price Target Upside17.17% Upside

Rating ConsensusModerate Buy

Number of Analyst Covering12

EPS Forecast (FY)2.86

Revenue Forecast (FY)CHF9.07B

Bulls Say, Bears Say

Bulls Say

Durable Revenue GrowthMulti-year revenue expansion indicates durable demand across Alcon’s eye-care portfolio rather than reliance on a single product or period. Continued growth across franchises and geographies can support operating scale, strengthen customer relationships, and provide a foundation for sustained earnings development.

Broad Product Momentum And Market PositionMarket-share gains in contact lenses and rapid adoption of newer products show that Alcon is converting innovation into commercial traction. A broad portfolio spanning surgical, contact-lens, and ocular-health categories can reinforce its competitive position and support recurring customer demand.

Strong Cash Generation And Conservative LeverageImproving free cash flow and conservative leverage give Alcon financial flexibility to fund product development, commercialization, and shareholder returns without relying heavily on additional borrowing. This supports resilience through investment cycles while preserving capacity for strategic capital allocation.

Bears Say

Recent Profitability And Return CompressionThe recent decline in net margin and ROE shows that revenue growth has not fully translated into stronger returns. If operating costs or pricing pressure persist, profitability may remain below prior levels, limiting earnings conversion and reducing the benefit of otherwise healthy gross margins.

PowerVision Program DiscontinuationEnding the PowerVision programs removes a potential long-term accommodating-IOL growth pathway and represents an R&D setback. It may also redirect development resources and leave Alcon with fewer future product options in an area where differentiated innovation could have strengthened its surgical portfolio.

Competitive And Adoption Pressure In Surgical ProductsSlower implantables growth and limited Hydrus adoption indicate that competitive launches, reimbursement changes, and customer uptake are constraining parts of Surgical. Persistent pressure in these categories could weaken portfolio growth and make future expansion more dependent on newer launches.

Alcon News

Alcon acquires Neurotech and expands retina portfolio with ENCELTO

Alcon (ALC) announced it has acquired Neurotech Pharmaceuticals, a company focused on developing innovative cell therapies for chronic...

2d ago

ALC

Alcon announces FDA approval of Brytly Redness Reliever Eye Drops

Alcon (ALC) announced that the U.S. FDA has approved Brytly Redness Reliever Eye Drops. With one drop, Brytly...

6d ago

ALC

Alcon price target lowered to $80 from $85 at Mizuho

Mizuho lowered the firm’s price target on Alcon (ALC) to $80 from $85 and keeps an Outperform rating...

10d ago

ALC

Alcon price target lowered to $74 from $82 at BTIG

BTIG lowered the firm’s price target on Alcon (ALC) to $74 from $82 and keeps a Buy rating...

11d ago

ALC

Flutter upgraded, AppFolio downgraded: Wall Street’s top analyst calls

The most talked about and market moving research calls around Wall Street are now in one place. Here...

15d ago

Alcon initiated with an Equal Weight at Barclays

Barclays analyst Christopher Pasquale initiated coverage of Alcon (ALC) with an Equal Weight rating and $70 price target...

16d ago

ALC

Alcon: Underperform Rating Reiterated as Analyst Flags Mounting Headwinds; $48 Price Target Maintained

In a report released yesterday, Julien Ouaddour from Bank of America Securities reiterated a Sell rating on Alcon,...

17d ago

ALC

Alcon price target lowered to $85 from $95 at Jefferies

Jefferies analyst Michael Sarcone lowered the firm’s price target on Alcon (ALC) to $85 from $95 and keeps...

1M ago

ALC

Alcon announces initial commercial launch of UNITY M

Alcon (ALC) announced the initial commercial launch of UNITY M, an Alcon brand premium surgical microscope that delivers...

2M ago

ALC

Largest borrow rate increases among liquid names

Latest data shows the largest indicative borrow rate increases among liquid option names include: Gorilla Technology Group Inc...

2M ago

ALC

DIA

Alcon price target raised to CHF 73 from CHF 70 at Deutsche Bank

Deutsche Bank raised the firm’s price target on Alcon (ALC) to CHF 73 from CHF 70 and keeps...

2M ago

ALC

Alcon Earnings Call Highlights Growth, Margins and Pipeline

Alcon (($CH:ALC)) has held its Q2 earnings call. Read on for the main highlights of the call. Alcon’s...

2M ago

ALC

Analyst Reiterates Buy on Alcon After Q2 Beat, Raised Earnings Outlook, and Strengthening Multi-Pillar Growth Drivers

David Saxon, an analyst from Needham, reiterated the Buy rating on Alcon. The associated price target is $95.00....

2M ago

ALC

Alcon Lifts 2026 Guidance After Strong Q2 Eye-Care Growth

An announcement from Alcon ( ($CH:ALC) ) is now available. Alcon reported second-quarter 2026 results on August 10,...

2M ago

ALC

ALC FAQ

What was Alcon Inc’s price range in the past 12 months?

Alcon Inc lowest stock price was CHF47.80 and its highest was CHF68.34 in the past 12 months.

What is Alcon Inc’s market cap?

Alcon Inc’s market cap is CHF27.94B.

When is Alcon Inc’s upcoming earnings report date?

Alcon Inc’s upcoming earnings report date is Nov 10, 2026 which is in 18 days.

How were Alcon Inc’s earnings last quarter?

Alcon Inc released its earnings results on Aug 10, 2026. The company reported CHF0.681 earnings per share for the quarter, beating the consensus estimate of CHF0.604 by CHF0.077.

Is Alcon Inc overvalued?

According to Wall Street analysts Alcon Inc’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Alcon Inc pay dividends?

Alcon Inc pays a Annually dividend of CHF0.28 which represents an annual dividend yield of 0.5%. See more information on Alcon Inc dividends here

What is Alcon Inc’s EPS estimate?

Alcon Inc’s EPS estimate is 0.72.

How many shares outstanding does Alcon Inc have?

Alcon Inc has 499,700,000 shares outstanding.

What happened to Alcon Inc’s price movement after its last earnings report?

Alcon Inc reported an EPS of CHF0.681 in its last earnings report, beating expectations of CHF0.604. Following the earnings report the stock price went up 4.698%.

Which hedge fund is a major shareholder of Alcon Inc?

Currently, no hedge funds are holding shares in CH:ALC

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Alcon Stock Smart Score

Outperform

Fundamentals

Return on Equity

2.91%

Trailing 12-Months

Asset Growth

-0.92%

Trailing 12-Months

Learn more about TipRanks Smart Score

Top Smart Score Stocks >

Company Description

Alcon Inc

Alcon Inc. is a global eye care enterprise dedicated to the research, development, manufacturing, and distribution of a comprehensive range of vision products for both eye care professionals and their patients worldwide. The company operates through two primary divisions. Its Surgical segment equips ophthalmic surgeons with advanced solutions for various procedures. This includes specialized equipment, diagnostic instrumentation, and implantable devices such as intraocular lenses (IOLs), alongside a full suite of consumables like viscoelastic substances, surgical solutions, and customized procedure kits. For cataract interventions, key offerings feature the Centurion Vision System, LenSx femtosecond laser, LuxOR surgical ophthalmic microscope, NGENUITY 3D visualization system, and ORA System for intra-operative measurements. Vitreoretinal surgeons benefit from systems like Constellation Vision, procedure packs, lasers, and a variety of specialized micro-instruments, including grieshaber and MIVS tools, scissors, forceps, medical-grade vitreous tamponades, and Hypervit vitrectomy probes. Refractive surgery innovations include WaveLight lasers and Contoura Vision for LASIK treatments, and the segment also provides the EX-PRESS glaucoma filtration device. Its IOL portfolio, prominently featuring AcrySof IQ, includes advanced technology lenses like PanOptix and ReSTOR, designed to correct presbyopia and astigmatism during cataract removal. The Vision Care segment addresses everyday eye health needs. It offers a diverse selection of contact lenses, including daily disposables, reusable options, and color-enhancing varieties. This segment also provides ocular health products for conditions such as dry eye, glaucoma, and allergies, in addition to contact lens care solutions, ocular vitamins, and redness-relieving drops. Prominent brands within this segment include TOTAL, PRECISION, DAILIES AquaComfort PLUS, Air Optix, Opti-Free, Clear Care, Tears Naturale, Genteal, ICAPS, and Vitalux. Founded in 1945, the company was initially known as Alcon Universal S.A. before rebranding as Alcon Inc. in December 2001. Its headquarters are located in Geneva, Switzerland.

Alcon (ALC) Earnings & Revenues

Historic Earnings Reports

ALC Company Deck

ALC Earnings Call

Q2 2026

0:00 / 0:00

Earnings Call Sentiment|Positive

The call conveyed a clearly positive operational and financial quarter: 7% consolidated sales growth, strong equipment performance (UNITY), margin expansion (+250 bps gross margin, +160 bps operating margin), EPS and cash-flow strength, and multiple successful new-product introductions (PanOptix Pro, TRYPTYR, Valeda). Notable negatives included the discontinuation of the PowerVision accommodating IOL program, slower growth in implantables and certain glaucoma products, a few one-time margin items and manufacturability timing for UNITY DX. On balance, the positives — consistent revenue and margin expansion, robust cash generation and multiple high-potential product rollouts and market-share gains — outweigh the setbacks.View all CH:ALC earnings summaries

ALC Stock 12 Month Forecast

Average Price Target

CHF68.80

▲(17.17% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"47":"CHF47","86":"CHF86","56.75":"CHF56.8","66.5":"CHF66.5","76.25":"CHF76.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":85,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">CHF85.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":68.80198123981819,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">CHF68.80</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":48,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">CHF48.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[47,56.75,66.5,76.25,86],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2026","6":"Apr<br/>2026","9":"Jul<br/>2026","12":"Oct<br/>2026","25":"Oct<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,52.86,55.332307692307694,57.80461538461538,60.276923076923076,62.74923076923077,65.22153846153846,67.69384615384615,70.16615384615385,72.63846153846154,75.11076923076922,77.58307692307693,80.05538461538461,82.5276923076923,{"y":85,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,52.86,54.08630624921678,55.312612498433566,56.53891874765035,57.76522499686713,58.991531246083916,60.2178374953007,61.44414374451749,62.670449993734266,63.89675624295106,65.12306249216783,66.34936874138462,67.5756749906014,{"y":68.80198123981819,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,52.86,52.48615384615385,52.112307692307695,51.738461538461536,51.364615384615384,50.99076923076923,50.61692307692308,50.24307692307692,49.86923076923077,49.495384615384616,49.121538461538464,48.747692307692304,48.37384615384615,{"y":48,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":59.132,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":59.51,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":63.431,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":62.974,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":61.66,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":65.024,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":59.789,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":57.938,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":51.72,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":53.78,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":55.38,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":58.3,"date":1788220800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":52.86,"date":1790812800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >